The Vanguard Group 13D and 13G filings for Integra LifeSciences Holdings Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-08-12 10:06 am Purchase |
2024-07-31 | 13G | Integra LifeSciences Holdings Corporation IART |
The Vanguard Group | 7,802,615 10.060% |
789,822 (+11.26%) |
Filing |
| 2024-02-13 5:06 pm Sale |
2023-12-29 | 13G | Integra LifeSciences Holdings Corporation IART |
The Vanguard Group | 7,012,793 8.970% |
-134,966 (-1.89%) |
Filing |
| 2023-02-09 11:22 am Purchase |
2022-12-30 | 13G | Integra LifeSciences Holdings Corporation IART |
The Vanguard Group | 7,147,759 8.560% |
488,637 (+7.34%) |
Filing |
| 2022-02-10 08:17 am Purchase |
2021-12-31 | 13G | Integra LifeSciences Holdings Corporation IART |
The Vanguard Group | 6,659,122 7.860% |
184,581 (+2.85%) |
Filing |
| 2021-02-10 11:03 am Sale |
2020-12-31 | 13G | Integra LifeSciences Holdings Corporation IART |
The Vanguard Group | 6,474,541 7.680% |
-176,158 (-2.65%) |
Filing |